Search for: "Anda Pharmaceuticals, Inc" Results 1 - 20 of 604
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
The Use of Mandated Public Disclosures of Clinical Trials as Prior Art Against Study Sponsors
16 Apr 2024, 8:42 am by Holman
Inc. v. [read post]
Patently-O - https://patentlyo.com
Federal Income Taxation of Intellectual Property Development and Cost Recovery
9 Apr 2024, 2:56 pm by Brian Clark
Proc. 97-35, and cases like RJR Nabisco, Inc. v. [read post]
Dollars & Sense - https://dollarsandsense.grayreed.com/
FTC’s Campaign Against Improper Orange Book Listings Continues with Amicus Brief in Teva’s Challenge of Amneal Asthma Inhaler ANDA
3 Apr 2024, 1:07 pm by Bevin Newman
The Federal Trade Commission (“FTC”) has filed an amicus brief in Teva Branded Pharmaceuticals Products R&D, Inc. v. [read post]
Antitrust Law Blog - http://www.antitrustlawblog.com/
Obviousness and Pharmaceutical Method of Treatment Claims
1 Apr 2024, 10:58 am by Dennis Crouch
Janssen Pharms., Inc. v. [read post]
Patently-O - https://patentlyo.com
FTC Continues to Rage Against Device Patent Listings in the Orange Book
26 Mar 2024, 7:01 pm by Kurt R. Karst
  Late last week, the FTC submitted an Amicus Brief in recent Hatch-Waxman patent litigation in the District Court of New Jersey between Reference Listed Drug holder Teva Branded Pharmaceutical Products R&D Inc. and ANDA applicant Amneal Pharmaceuticals explaining that patents that claim the device constituent of a combination product but do not expressly claim the relevant drug substance should not be listed in the Orange Book. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
Obviousness: Is a Reasonable Expectation of Success Sufficient
19 Feb 2024, 12:55 pm by Dennis Crouch
  Teva and Apotex, filed Abbreviated New Drug Applications (ANDAs) with the FDA seeking to market generic versions of the $100m+ drug. [read post]
Patently-O - https://patentlyo.com
Federal Circuit Affirms Skinny Label Carve Outs
18 Jan 2024, 9:16 am by Fred Chung, Bradley Graveline and James Hurt
Teva Pharmaceuticals USA, Inc., 7 F.4th 1320, 1333 (Fed. [read post]
Intellectual Property Law Blog - http://www.intellectualpropertylawblog.com/
H. Lundbeck A/S v. Lupin Ltd. (Fed. Cir. 2023)*
18 Dec 2023, 9:07 pm by Patent Docs
Mylan Pharmaceuticals Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Skinny Label Avoids Infringement
7 Dec 2023, 1:47 pm by Dennis Crouch
Teva Pharmaceuticals USA, Inc., 7 F.4th 1320, 1333 (Fed. [read post]
Patently-O - https://patentlyo.com
Rounding the Bend: Claim Construction and the Role of Extrinsic Evidence
6 Nov 2023, 8:35 am by Dennis Crouch
Mylan Pharmaceuticals Inc., No. 2022-1889 (Fed. [read post]
Patently-O - https://patentlyo.com
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2023)
11 Jun 2023, 8:17 pm by Patent Docs
Teva Pharmaceuticals USA, Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Congressional redistricting, patent infringement, arbitration, and the Armed Career Criminal Act
11 May 2023, 1:16 pm by John Elwood
New Relists Teva Pharmaceuticals USA, Inc. v. [read post]
SCOTUSblog - http://www.scotusblog.com/
Obviousness and Stereochemistry
21 Apr 2023, 7:07 am by Jordan Duenckel
Amgen Inc., v. [read post]
Patently-O - https://patentlyo.com
Southern District of Florida Dismisses Patent Infringement Claims for Generalized Allegations and Declaratory Judgment Claims for Lack of Sufficient Immediacy
17 Jan 2023, 6:30 am by Charles H. Chevalier and Christine A. Gaddis
In Scilex Pharmaceuticals Inc. v. [read post]
Real Property & Environmental Law Alert - http://www.rpelawalert.com/
Southern District of Florida Dismisses Patent Infringement Claims for Generalized Allegations and Declaratory Judgment Claims for Lack of Sufficient Immediacy
17 Jan 2023, 6:30 am by Charles H. Chevalier and Christine A. Gaddis
In Scilex Pharmaceuticals Inc. v. [read post]
IP Law Alert - http://www.iplawalert.com
Southern District of Florida Dismisses Patent Infringement Claims for Generalized Allegations and Declaratory Judgment Claims for Lack of Sufficient Immediacy
17 Jan 2023, 6:30 am by Charles H. Chevalier and Christine A. Gaddis
In Scilex Pharmaceuticals Inc. v. [read post]
Employment Law Alert - http://www.employmentlawalert.com
Genentech, Inc. v. Sandoz Inc. (Fed. Cir. 2022)
27 Dec 2022, 7:01 pm by Patent Docs
These issues arose in ANDA litigation brought by Genentech and InterMune against ANDA filer Sandoz and its supplier LEK Pharmaceuticals. [read post]
Patent Docs - http://www.patentdocs.org/
DNJ Court Grants Motion to Dismiss Based on Covenant Not to Sue
5 Dec 2022, 6:55 am by Charles H. Chevalier and Christine A. Gaddis
In Teva Branded Pharmaceutical Products R&D, Inc. v. [read post]
Employment Law Alert - http://www.employmentlawalert.com
DNJ Court Grants Motion to Dismiss Based on Covenant Not to Sue
5 Dec 2022, 6:55 am by Charles H. Chevalier and Christine A. Gaddis
In Teva Branded Pharmaceutical Products R&D, Inc. v. [read post]
IP Law Alert - http://www.iplawalert.com
DNJ Court Grants Motion to Dismiss Based on Covenant Not to Sue
5 Dec 2022, 6:55 am by Charles H. Chevalier and Christine A. Gaddis
In Teva Branded Pharmaceutical Products R&D, Inc. v. [read post]
Real Property & Environmental Law Alert - http://www.rpelawalert.com/